EBR Systems, Inc.
EBR Systems, Inc. (EBRCZ) Stock Overview
Explore EBR Systems, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
204.4M
P/E Ratio
-0.02
EPS (TTM)
$-0.12
ROE
-2.89%
EBRCZ Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of EBR Systems, Inc. (EBRCZ) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $0.38.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.02 and a market capitalization of 204.4M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.
Company Profile
EBR Systems, Inc. develops implantable systems for wireless tissue stimulation. The company offers WiSE cardiac resynchronization therapy system that uses a proprietary wireless technology to deliver pacing stimulation directly to the inside of the left ventricle of the heart. Its products are used to eliminate lead complications, such as placement difficulty, unintended nerve stimulation, dislodgement, extraction, and repositioning. The company was incorporated in 2003 and is based in Sunnyvale, California.
John Graham McCutcheon
89
480 Oakmead Parkway, Sunnyvale, CA
2023